THERAPEUTIC POTENTIAL OF FUNCTIONAL PRODUCT BASED ON WILD EDIBLE MUSHROOMS

Food supplements have proven their effectiveness through the support offered to administer certain drugs and their ability to determine the prevention of degenerative diseases. The correlation of assay methods with individual-level observations is essential in understanding the effect of biopharmaceuticals as a useful tool for long-term homeostasis preservation. This paper aimed to present essential aspects related to using wild edible mushrooms as functional supplements in type 2 diabetes and associated cardiovascular diseases. The product RoBioMush was presented as a result of the scientific data applied within the university, and the effects recorded after the administration of the product to the target groups were highlighted. Thus, the administration of RoBioMush had as its main effect the regulation of intestinal transit, a fact demonstrated by the researched modulation process previously in an in vitro study.